SCHEMBL16508324

SCHEMBL16508324

Cc1ccc(CNC=O)cc1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.50
ADH1C P00326 1/20 0.50
ADH1A P07327 1/20 0.50
ADH7 P40394 1/20 0.50
ROCK2 O75116 1/20 0.41
CHEK2 O96017 1/20 0.41
PRKACA P17612 1/20 0.41
RPS6KB1 P23443 1/20 0.41
AKT1 P31749 1/20 0.41
MATK P42679 1/20 0.41
GSK3A P49840 1/20 0.41
GSK3B P49841 1/20 0.41
RPS6KA3 P51812 1/20 0.41
NEK4 P51957 1/20 0.41
ROCK1 Q13464 1/20 0.41
PRKG1 Q13976 1/20 0.41
PKN2 Q16513 1/20 0.41
CDC42BPA Q5VT25 1/20 0.41
HIPK4 Q8NE63 1/20 0.41
AURKB Q96GD4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8763600 0.85 ADH1B (0.47) ADH1BADH1CADH1AADH7NR1H4
SCHEMBL5990330 0.83 ADH1B (0.46) ADH1BADH1CADH1AADH7MAPT
SCHEMBL2586904 0.83 ADH1B (0.46) ADH1BADH1CADH1AADH7NPC1
SCHEMBL3304927 0.83 HDAC3 (0.49) ADH1BADH1CADH1AADH7
SCHEMBL27199447 0.81 ALKBH5 (0.49) ROCK2CHEK2PRKACARPS6KB1AKT1
SCHEMBL30498104 0.81 ALKBH5 (0.49) ROCK2CHEK2PRKACARPS6KB1AKT1
SCHEMBL17503952 0.80 ADH1B (0.43) ADH1BADH1CADH1AADH7
SCHEMBL5990841 0.80 HTR7 (0.47) ADH1BADH1CADH1AADH7NPC1
SCHEMBL8763196 0.78 ADH1B (0.76) ADH1BADH1CADH1AADH7LMNA
SCHEMBL31566 0.77 ADH1B (0.61) ADH1BADH1CADH1AADH7NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3608317-A1 COMPOUNDS & METHODS FOR THE ENHANCED DEGRADATION OF TARGETED PROTEINS & OTHER POLYPEPTIDES BY AN E3 UBIQUITIN LIGASE Yale University (US) 2020-02-12 EP disclosed
US-20110294118-A1 WATER SOLUBLE FLUORESCENT COMPOUNDS BIOSEARCH TECHNOLOGIES, INC. (US) 2011-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294118-A1 WATER SOLUBLE FLUORESCENT COMPOUNDS ABCG2, AQP1, AQP3 ADH1B 1114/4885ADH1C 2272/4885ADH1A 1518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.